Overview
YOUR SOURCE FOR SUCCESS IN PHARMA AND DEVICE SERVICES INVESTING
Join C-suite executives, senior private equity professionals, investment bankers and other industry leaders for a deep dive into the investment opportunities and emerging trends shaping Pharma and Device Services – 2024’s hottest sector.
With a rebound in biopharma funding, innovations in medtech solutions, growth in R&D activity from large pharmaceutical and biotechnology companies, and increased clinical trial and supply chain complexity, investor interest in Pharma and Device Services is on the rise. Management teams throughout the Pharma Services and MedTech value chain are navigating increased competition, changing technology and shifting customer demands, which creates opportunities for private equity investors to add value.
McDermott’s inaugural Pharma and MedTech Services Investment Summit 2024 is here to help you navigate this growing and complex space.
WHAT YOU’LL EXPERIENCE:
- Four sessions that will explore merger and acquisition trends, global regulatory developments and technology-driven innovations in key subsectors
- Insights from private equity and venture capital investors, CEOs and other C-suite executives, investment bankers and McDermott lawyers, as well as a market outlook presented by McKinsey & Company
- Several networking opportunities to help you forge meaningful connections and strategic partnerships
